Labeling anti-HER2/neu monoclonal antibodies with 111In and 90Y using a bifunctional DTPA chelating agent

Cancer Biotherapy and Radiopharmaceuticals

Volumn 18, Issue 3, 2003, Pages 355-363

  Blend, Michael J ^a,d   Stastny, Jerry J ^a   Swanson, Steven M ^b   Brechbiel, Martin W ^c  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF ILLINOIS HOSPITAL AND HEALTH SCIENCES SYSTEM   (United States)

Author keywords

In 111; Radiolabeled Herceptin ; Y 90 labeled anti HER2 neu antibodies

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; ANTIBODY CONJUGATE; CHELATING AGENT; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; INDIUM CHLORIDE IN 111; MEMBRANE RECEPTOR; MONOCLONAL ANTIBODY; PENTETIC ACID; PENTETIC ACID DERIVATIVE; TRASTUZUMAB; YTTRIUM 90;

ANTIBODY LABELING; ARTICLE; BINDING ASSAY; BREAST TUMOR; CANCER CELL CULTURE; CELL STRAIN MCF 7; CELL SURFACE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG CONJUGATION; DRUG PURIFICATION; DRUG RECEPTOR BINDING; DRUG STABILITY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; ISOTOPE LABELING; ONCOGENE NEU; PLASMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; THERMOSTABILITY; TUMOR XENOGRAFT;

EID: 0042743916     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/108497803322285107     Document Type: Article

References (13)

1. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987;235:177-182.
2. Semba K, Kamata N, Toyoshima K, Yamamoto T. A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma. Proc Natl Acad Sci USA 1985;82:6497-6501.
3. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989;244:707-712.
4. Pauletti G, Godolphin W, Press MF, Slamon DJ. Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization. Oncogene 1996;13:63-72.
5. Cobleigh MA, Vogel CL, Tripathy D, Robert NJ, Scholl S, Fehrenbacher L, Wolter JM, Paton V, Shak S, Lieberman G, Slamon DJ. Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J Clin Oncol 1999;17:2639-2648.
6. Carter P, Presta L, Gorman CM, Ridgway JB, Henner D, Wong WL, Rowland AM, Kotts C, Carver ME, Shephard HM. Humanization of an anti-p185HER-2 antibody for human cancer therapy. Proc Natl Acad Sci USA 1992;89:4285-4289.
7. Sliwkowski MX, Lofgren JA, Lewis GD, Hotaling TE, Fendly BM, Fox JA. Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin). Semin Oncol 1999;26:60-70.
8. DeNardo GL, DeNardo SJ. Prospective on the future of radioimmunodiagnosis and radioimmunotherapy of cancer. In: Burchiel SW, Rhodes BA, eds. Radioimmunoimaging and radioimmunotherapy. New York: Elsevier Science Publishing Co., Inc.; 1983;41-62.
9. IDEC Package Insert, 2001.
10. Li M, Meares CF. Synthesis, metal chelate stability studies, and enzyme digestion of a peptide-linked DOTA derivative and its corresponding radiolabeled immunoconjugates. Bioconjug Chem 1993;4:275-283.
11. Pippin CG, Parker, TA, McMurry TJ, Brechbiel MW. Spectrophotometric method for the determination of a bifunctional DTPA ligand in DTPA-monoclonal antibody conjugates. Bioconjug Chem 1992;3:342-345.
12. Wu C, Kobayashi H, Sun B, Yoo TM, Paik CH, Gansow OA, Carrasquillo JA, Pastan I, Brechbiel MW. Stereochemical influence on the stability of radiometal complexes in vivo. Synthesis and evaluation of the four stereoisomers of 2-(p-nitrobenzyl)-trans-CyDTPA. Bioorg Med Chem 1997;5:1925-1934.
13. Nikula TK, Curcia MJ, Brechbiel MW, Gansow OA, Finn RD, Scheinberg DA. A rapid single vessel method for preparation of clinical grade ligand conjugated monoclonal antibodies. Nucl Med Biol 1995;22:387-390.